Episode
Hope Near Home for Pancreatic Cancer | Burlington News
- Published
- Sep 3, 2026
- Duration seconds
- 77
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/e899c2a9638fd77f
Actions
POST https://stenobird.com/v1/public/podcasts/burlington-news-today-2-min-news-the-daily-news-now-7606141/episodes/hope-near-home-for-pancreatic-cancer-burlington-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/burlington-news-today-2-min-news-the-daily-news-now-7606141/hope-near-home-for-pancreatic-cancer-burlington-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
FDA just approved a groundbreaking new oral treatment for pancreatic cancer — one of the first in years to show real promise in extending life and improving quality. Developed with local input, UVM Cancer Center led the research and included 12 Vermont patients in the trial. Dr. Randall Holcombe calls it a major leap forward against this aggressive disease. The center’s mission? Bring cutting-edge care closer to home — especially for rural patients. Survivor Michael Kennedy credits UVMCC for letting him stay local, preserving his routine and support system during treatment. This win means hope and accessibility for patients across Vermont and Northern New York. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/e899c2a9638fd77f